Clinical Trial Update: A Study of Decitabine (DACOGEN) in Sequential Administration With Cytarabine in Children With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating sequential decitabine with cytarabine in children with relapsed or refractory acute myeloid leukemia; study terminated with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Decitabine (Decitabine)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-06-17